RC
PFE icon

Rahlfs Capital’s Pfizer PFE Stock Holding History

Rahlfs Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Hold
37,686
– – 0.78% 41
2025
Q4 		$938K Sell
37,686
-867
-2% -$21.9K 0.73% 38
2025
Q3 		$982K Sell
38,553
-800
-2% -$19.7K 0.78% 40
2025
Q2 		$954K Buy
39,353
+900
+2% +$21K 0.87% 37
2025
Q1 		$974K Sell
38,453
-1,500
-4% -$39.3K 0.98% 34
2024
Q4 		$1.06M Buy
+39,953
New +$1.08M 1.05% 28

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Rahlfs Capital's PFE Position: Q1 2026 in Review

Rahlfs Capital held its Pfizer (PFE) position steady in Q1 2026 at 37,686 shares worth $1.06M. The position accounts for 0.78% of the portfolio, ranked #41.

Rahlfs Capital first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.06M in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Rahlfs Capital held 37,686 shares of Pfizer worth $1.06M as of Q1 2026.
  • Rahlfs Capital left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.78% of Rahlfs Capital's portfolio in Q1 2026, its #41 holding.
  • Rahlfs Capital first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Rahlfs Capital's Pfizer position peaked at $1.06M in Q4 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Rahlfs Capital's 13F filing for Q1 2026, filed 11 May 2026.